Fact CheckerSign in

NCT07414914Recruiting

Self-Myofascial Release Plus Exercise Versus Exercise Alone in Type 2 Diabetes

The Effect of the Addition of Myofascial Release to Exercise Program on Foot Function, Physical Performance, and Plantar Fascia Thickness in Individuals With Type 2 Diabetes: A Randomized Controlled Trial

Source: ClinicalTrials.gov · Last updated 17 Feb 2026

Brief summary (registry, in English)

This randomized controlled trial aims to investigate the effects of adding self-myofascial release applied to the plantar fascia and gastrosoleus muscles to an exercise program on foot function, physical performance, and plantar fascia thickness in individuals with type 2 diabetes. Participants aged 30 to 65 years with controlled type 2 diabetes will be randomly allocated to either an exercise-only group or an exercise plus self-myofascial release group. Both groups will complete an eight-week supervised exercise program three times per week. The intervention group will additionally perform self-myofascial release using a foam roller before exercise sessions. Outcomes will include foot function, balance, functional mobility, gait performance, and plantar fascia thickness assessed by ultrasonography before and after the intervention.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
40 (estimated)
First submitted
11 Feb 2026
Start date
3 Nov 2025
Primary completion date
4 May 2026
Lead sponsor
Izmir Katip Celebi University
NCT number
NCT07414914

What you commit to

  • Study type: Interventional
  • Planned participants: 40
  • From 3 Nov 2025 to the primary completion date, 4 May 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • History of plantar fasciitis
  • Diagnosed peripheral vascular disease
  • History of lower extremity surgery or fracture during last year
  • Rheumatologic or connective tissue disorders affecting soft tissue properties
  • Neurological or diagnosed cognitive disorders
  • Other types of diabetes mellitus
  • Serious cardiopulmonary disorders, including heart failure, history of myocardial infarction, or severe chronic obstructive pulmonary disease or asthma

Other

  • Severe pes planus or pes cavus defined by the Foot Posture Index-6 (FPI-6) (score ≥ +10 or ≤ -5)
  • Plantar fascia ulceration
  • Peripheral neuropathy
  • Pregnancy
  • Obesity (BMI \> 30 kg/m²)

Who the study is looking for

  • Individuals aged 30 to 65 years
  • Diagnosed with type 2 diabetes mellitus for at least 1 year
  • Controlled type 2 diabetes mellitus
  • Able to ambulate independently without assistive devices

Age in the registry: 30 years to 65 years · Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Bakırçay University Çiğli Regional Education Hospital
Coordinator of this site? Confirm its status
IzmirTurkey (Türkiye)Recruiting

This page is information, not medical advice. Discuss any trial with your doctor.